2 weeks Ago By Defense World Staff
NRx Pharmaceuticals ( NASDAQ:NRXP – Get Free Report ) is set to announce its earnings results after the market closes on Thursday, November 14th. Analysts expect the company to announce earnings of ($0.81) per share for the quarter.
Investors that wish to register for the company’s conference call can do so using this link . NRx Pharmaceuticals ( NASDAQ:NRXP – Get Free Report ) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.
75) EPS for the quarter, topping the consensus estimate of ($0.81) by $0.06.
On average, analysts expect NRx Pharmaceuticals to post $-3 EPS for the current fiscal year and $-1 EPS for the next fiscal year. NRx Pharmaceuticals Trading Down 0.8 % Shares of NRXP opened at $1.
26 on Wednesday. NRx Pharmaceuticals has a 1-year low of $1.10 and a 1-year high of $7.
33. The firm’s 50-day moving average price is $1.48 and its 200-day moving average price is $2.
26. The firm has a market capitalization of $13.55 million, a price-to-earnings ratio of -0.
47 and a beta of 1.27. Analyst Upgrades and Downgrades View Our Latest Research Report on NRx Pharmaceuticals About NRx Pharmaceuticals ( Get Free Report ) NRx Pharmaceuticals, Inc, a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain.
Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned food and drug administration-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior. See Also Five stocks we like better than NRx Pharmaceuticals 3 Tickers Leading a Meme Stock Revival Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025 What is the Dogs of the Dow Strategy? Overview and Examples Is Tesla’s Valuation a Bubble or Backed by Real Growth? What is MarketRankTM? How to Use it Trucking Stocks Led the Pack Last Week: Can They Keep Rolling? Receive News & Ratings for NRx Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NRx Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter .
.
